CoChat
Sign Up
Cited by 215Retinal Diseases and TreatmentsAntioxidant Activity and Oxidative StressOphthalmology and Visual Impairment Studies

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Associations of Mortality With Ocular Disorders and an Interventionof High-Dose Antioxidants and Zinc in the Age-Related Eye Disease Study: AREDS Report No. 13

Open access
AREDS Research Group·2004·Archives of Ophthalmology
DOI 10.1001/archopht.122.5.716PMC PMC1473208
Open this paper in CoChat — free accountOpen PDF

Abstract

OBJECTIVE: To assess the association of ocular disorders and high doses of antioxidants or zinc with mortality in the Age-Related Eye Disease Study (AREDS). METHODS: Baseline fundus and lens photographs were used to grade the macular and lens status of AREDS participants. Participants were randomly assigned to receive oral supplements of high-dose antioxidants, zinc, antioxidants plus zinc, or placebo. Risk of all-cause and cause-specific mortality was assessed using adjusted Cox proportional hazards models. RESULTS: During median follow-up of 6.5 years, 534 (11%) of 4753 AREDS participants died. In fully adjusted models, participants with advanced age-related macular degeneration (AMD) compared with participants with few, if any, drusen had increased mortality (relative risk [RR], 1.41; 95% confidence interval [CI], 1.08-1.86). Advanced AMD was associated with cardiovascular deaths. Compared with participants having good acuity in both eyes, those with visual acuity worse than 20/40 in 1 eye had increased mortality (RR, 1.36; 95% CI, 1.12-1.65). Nuclear opacity (RR, 1.40; 95% CI, 1.12-1.75) and cataract surgery (RR, 1.55; 95% CI, 1.18-2.05) were associated with increased all-cause mortality and with cancer deaths. Participants randomly assigned to receive zinc had lower mortality than those not taking zinc (RR, 0.73; 95% CI, 0.61-0.89). CONCLUSIONS: The decreased survival of AREDS participants with AMD and cataract suggests that these conditions may reflect systemic rather than only local processes. The improved survival in individuals randomly assigned to receive zinc requires further study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/archopht.122.5.716

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Food and Nutrition Board, National Academy of Sciences. Zinc. In: Dietary Ref- erence Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Io- dine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Wash- ington, DC: National Academy Press; 2002.

Cited by

Sorted by citations

See all 215

Related

See all

Metadata

Authors
AREDS Research Group
Affiliations
Emmes (United States) (US)
Corresponding author
AREDS Research Group
Venue
Archives of Ophthalmology
Publisher
American Medical Association (AMA)
Published
2004-05-01
Volume
122
Issue
5
Pages
716
ISSN
0003-9950 (ISSN-L)
DOI
10.1001/archopht.122.5.716
PMC
PMC1473208
OpenAlex
W1548644132
Cited by
215
References
32
Citations by year
2026: 3 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 9 · 2020: 8 · 2019: 8 · 2018: 6 · 2017: 11 · 2016: 11 · 2015: 7 · 2014: 15 · 2013: 8 · 2012: 15
FWCI
18.81
Type
journal article
Language
en
Open access
Locations
  • Archives of Ophthalmology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (1z01ey000394-01)
  • National Eye Institute (Z01 EY000394-03)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
Keywords
eye diseases, mortality, age-related macular degeneration, drusen, visual acuity, nuclear lens opacity, cataract surgery, cataract, antioxidants, zinc supplementation, all-cause mortality, cardiovascular mortality, cancer mortality
MeSH terms
Aged, Aged, 80 and over, Aging, Antioxidants, Ascorbic Acid, Cataract, Cataract Extraction, Cause of Death, Drug Therapy, Combination, Female, Humans, Macular Degeneration, Male, Middle Aged, United States, Vision Disorders, Vitamin E, Zinc Oxide, Survival Rate, Proportional Hazards Models, beta Carotene, Visually Impaired Persons, Persons with Visual Disabilities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review